AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

QIAGEN N.V. to Report First Quarter 2019 Results

April 15, 2019

VENLO, The Netherlands--(BUSINESS WIRE)--Apr 15, 2019--QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) plans as previously announced to release its report on results for the first quarter 2019 on Monday, May 6 at approximately 22:05 Central European Time (CET) / 16:05 Eastern Standard Time (EDT). A conference call is planned for Tuesday, May 7 at 15:00 CET / 9:00 EDT hosted by Peer M. Schatz, Chief Executive Officer, and Roland Sackers, Chief Financial Officer.

Conference Call and Webcast Details
The conference call will begin at 15:00 CET / 9:00 EDT on Tuesday May 7, 2019.

Interested parties may listen to the call by dialing:
+1 929 477 0448 (U.S.), +44 (0)330 336 9125 (UK), +49 (0)69 2222 25574 (Germany).
To avoid waiting time, please join the event conference 5-10 minutes prior to the start time.
Quoting the following Conference ID: 9120987 to the answering operator.

The webcast will be accessible at:
https://globalmeet.webcasts.com/starthere.jsp?ei=1236909&tp_key=fb3cd2e147

A conference call replay will be available by using the following link:
https://globalmeet.webcasts.com/starthere.jsp?ei=1236909&tp_key=fb3cd2e147

Contact: IR@qiagen.com

About QIAGEN

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (primarily forensics), Pharma (pharma and biotech companies) and Academia (life sciences research).
As of December 31, 2018, QIAGEN employed approximately 5,000 people in over 35 locations worldwide. Further information can be found at http://www.qiagen.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190415005386/en/

CONTACT: John Gilardi

Vice President Corporate Communications and Investor Relations

+49 2103 29 11711

+1 240 686 2222

Email:ir@qiagen.comPhoebe Loh

Associate Director Investor Relations

+49 2103 29 11457

Email:ir@qiagen.com

KEYWORD: EUROPE NETHERLANDS

INDUSTRY KEYWORD: TECHNOLOGY SOFTWARE HEALTH BIOTECHNOLOGY CLINICAL TRIALS RESEARCH SCIENCE

SOURCE: QIAGEN

Copyright Business Wire 2019.

PUB: 04/15/2019 06:54 AM/DISC: 04/15/2019 06:54 AM

http://www.businesswire.com/news/home/20190415005386/en